Mei Baisong's most recent trade in Editas Medicine Inc was a trade of 541 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on Dec. 3, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Editas Medicine Inc | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.08 per share. | 03 Dec 2024 | 541 | 133,354 (0%) | 0% | 2.1 | 1,124 | Common Stock |
Editas Medicine Inc | Baisong Mei | EVP, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 3.42 per share. | 04 Sep 2024 | 518 | 133,895 (0%) | 0% | 3.4 | 1,774 | Common Stock |
Editas Medicine Inc | Baisong Mei | EVP, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.21 per share. | 19 Jul 2024 | 6,619 | 134,413 (0%) | 0% | 5.2 | 34,456 | Common Stock |
Editas Medicine Inc | Baisong Mei | EVP, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.50 per share. | 04 Jun 2024 | 511 | 141,032 (0%) | 0% | 5.5 | 2,808 | Common Stock |
Editas Medicine Inc | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 152,800 | 152,800 | - | - | Stock Option (right to buy) | |
Editas Medicine Inc | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 50,900 | 122,955 (0%) | 0% | 0 | Common Stock | |
Editas Medicine Inc | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.42 per share. | 02 Mar 2024 | 20,327 | 141,543 (0%) | 0% | 9.4 | 191,425 | Common Stock |
Editas Medicine Inc | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 19,458 | 142,413 (0%) | 0% | 0 | Common Stock | |
Editas Medicine Inc | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 19,457 | 161,870 (0%) | 0% | 0 | Common Stock | |
Editas Medicine Inc | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.80 per share. | 19 Jul 2023 | 4,317 | 72,055 (0%) | 0% | 8.8 | 37,990 | Common Stock |
Editas Medicine Inc | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 54,000 | 54,000 | - | - | Stock Option (right to buy) | |
Editas Medicine Inc | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 18,000 | 76,372 (0%) | 0% | 0 | Common Stock | |
Editas Medicine Inc | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 171,602 | 171,602 | - | - | Stock Option (right to buy) | |
Editas Medicine Inc | Baisong Mei | SVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 58,372 | 58,372 (0%) | 0% | 0 | Common Stock |